Gabelli Funds’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $997K | Hold |
28,200
| – | – | 0.01% | 896 |
|
|
2025
Q4 | $1.14M | Hold |
28,200
| – | – | 0.01% | 871 |
|
|
2025
Q3 | $1.33M | Hold |
28,200
| – | – | 0.01% | 851 |
|
|
2025
Q2 | $1.47M | Hold |
28,200
| – | – | 0.01% | 811 |
|
|
2025
Q1 | $1.7M | Hold |
28,200
| – | – | 0.01% | 685 |
|
|
2024
Q4 | $1.93M | Hold |
28,200
| – | – | 0.01% | 659 |
|
|
2024
Q3 | $2.03M | Hold |
28,200
| – | – | 0.01% | 653 |
|
|
2024
Q2 | $1.95M | Hold |
28,200
| – | – | 0.01% | 664 |
|
|
2024
Q1 | $2.26M | Hold |
28,200
| – | – | 0.02% | 634 |
|
|
2023
Q4 | $3.09M | Sell |
28,200
-800
| -3% | -$82.7K | 0.02% | 564 |
|
|
2023
Q3 | $2.92M | Sell |
29,000
-500
| -2% | -$57.5K | 0.02% | 571 |
|
|
2023
Q2 | $4.01M | Hold |
29,500
| – | – | 0.03% | 505 |
|
|
2023
Q1 | $3.06M | Sell |
29,500
-400
| -1% | -$38.7K | 0.02% | 574 |
|
|
2022
Q4 | $2.65M | Sell |
29,900
-500
| -2% | -$41.5K | 0.02% | 600 |
|
|
2022
Q3 | $2.44M | Hold |
30,400
| – | – | 0.02% | 614 |
|
|
2022
Q2 | $2.91M | Hold |
30,400
| – | – | 0.02% | 585 |
|
|
2022
Q1 | $4.52M | Sell |
30,400
-500
| -2% | -$69.8K | 0.03% | 529 |
|
|
2021
Q4 | $4.38M | Hold |
30,900
| – | – | 0.03% | 547 |
|
|
2021
Q3 | $4.04M | Sell |
30,900
-500
| -2% | -$65.4K | 0.03% | 564 |
|
|
2021
Q2 | $4.32M | Hold |
31,400
| – | – | 0.03% | 566 |
|
|
2021
Q1 | $4.1M | Sell |
31,400
-1,500
| -5% | -$181K | 0.03% | 555 |
|
|
2020
Q4 | $3.69M | Sell |
32,900
-2,500
| -7% | -$237K | 0.03% | 551 |
|
|
2020
Q3 | $2.79M | Sell |
35,400
-200
| -0.6% | -$16.3K | 0.02% | 594 |
|
|
2020
Q2 | $2.56M | Hold |
35,600
| – | – | 0.02% | 596 |
|
|
2020
Q1 | $2.04M | Sell |
35,600
-3,100
| -8% | -$286K | 0.02% | 636 |
|
|
2019
Q4 | $4.33M | Sell |
38,700
-10,800
| -22% | -$1.15M | 0.03% | 542 |
|
|
2019
Q3 | $4.76M | Sell |
49,500
-500
| -1% | -$46.9K | 0.03% | 525 |
|
|
2019
Q2 | $4.28M | Sell |
50,000
-10,000
| -17% | -$822K | 0.03% | 572 |
|
|
2019
Q1 | $4.99M | Sell |
60,000
-12,000
| -17% | -$872K | 0.03% | 533 |
|
|
2018
Q4 | $4.62M | Sell |
72,000
-1,500
| -2% | -$103K | 0.03% | 520 |
|
|
2018
Q3 | $5.82M | Sell |
73,500
-2,500
| -3% | -$193K | 0.03% | 534 |
|
|
2018
Q2 | $5.56M | Sell |
76,000
-4,500
| -6% | -$306K | 0.03% | 541 |
|
|
2018
Q1 | $5.1M | Sell |
80,500
-2,500
| -3% | -$149K | 0.03% | 549 |
|
|
2017
Q4 | $4.23M | Hold |
83,000
| – | – | 0.02% | 608 |
|
|
2017
Q3 | $4.36M | Hold |
83,000
| – | – | 0.02% | 604 |
|
|
2017
Q2 | $4.23M | Sell |
83,000
-2,000
| -2% | -$99K | 0.03% | 603 |
|
|
2017
Q1 | $3.77M | Hold |
85,000
| – | – | 0.02% | 623 |
|
|
2016
Q4 | $3.75M | Hold |
85,000
| – | – | 0.02% | 623 |
|
|
2016
Q3 | $3.4M | Hold |
85,000
| – | – | 0.02% | 656 |
|
|
2016
Q2 | $4.06M | Hold |
85,000
| – | – | 0.02% | 604 |
|
|
2016
Q1 | $3.56M | Hold |
85,000
| – | – | 0.02% | 630 |
|
|
2015
Q4 | $3.74M | Hold |
85,000
| – | – | 0.02% | 605 |
|
|
2015
Q3 | $4.06M | Sell |
85,000
-3,000
| -3% | -$165K | 0.02% | 596 |
|
|
2015
Q2 | $5.13M | Hold |
88,000
| – | – | 0.03% | 576 |
|
|
2015
Q1 | $4.44M | Sell |
88,000
-1,000
| -1% | -$49K | 0.02% | 615 |
|
|
2014
Q4 | $4M | Sell |
89,000
-1,000
| -1% | -$41.9K | 0.02% | 653 |
|
|
2014
Q3 | $3.32M | Hold |
90,000
| – | – | 0.02% | 686 |
|
|
2014
Q2 | $3.97M | Sell |
90,000
-1,000
| -1% | -$45.3K | 0.02% | 649 |
|
|
2014
Q1 | $3.95M | Hold |
91,000
| – | – | 0.02% | 628 |
|
|
2013
Q4 | $3.87M | Sell |
91,000
-5,000
| -5% | -$190K | 0.02% | 627 |
|
|
2013
Q3 | $3.26M | Hold |
96,000
| – | – | 0.02% | 650 |
|
|
2013
Q2 | $3M | Buy |
+96,000
| New | +$3.12M | 0.02% | 634 |
|
Other funds holding CNMD
VPM
VCM
CB
Gabelli Funds's CNMD Position: Q1 2026 in Review
Gabelli Funds held its CONMED (CNMD) position steady in Q1 2026 at 28,200 shares worth $997K. The position accounts for 0.01% of the portfolio, ranked #896.
Gabelli Funds first reported a position in CNMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.82M in Q3 2018. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Gabelli Funds held 28,200 shares of CONMED worth $997K as of Q1 2026.
- Gabelli Funds left its CONMED share count unchanged in Q1 2026.
- CONMED made up 0.01% of Gabelli Funds's portfolio in Q1 2026, its #896 holding.
- Gabelli Funds first reported a position in CONMED in Q2 2013 and has held it in 52 quarters since.
- Gabelli Funds's CONMED position peaked at $5.82M in Q3 2018.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Gabelli Funds's 13F filing for Q1 2026, filed 14 May 2026.